Chemical Compound
6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-Luteinizing hormone-releasing factor (swine) acetate (1:1); 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt) (9CI); Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt); 1-9-Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt); Buserelin acetate; Conceptal; Estomal; Gonaxal; Sprecur MP; Suprafact; Suprecur; Supremon
CAS Registry Number
68630-75-1
Primary record
6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-Luteinizing hormone-releasing factor (swine) acetate (1:1); 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt) (9CI); Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt); 1-9-Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt); Buserelin acetate; Conceptal; Estomal; Gonaxal; Sprecur MP; Suprafact; Suprecur; Supremon
- 库存
- 1,336 克
- 纯度
- 99.3 %
- CAS
- 68630-75-1
化合物标识与属性
- CAS
- 68630-75-1
- PubChem CID
- 50224
- SMILES
- CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O
- Canonical SMILES
- CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1
名称与同义词
- Buserelin acetate
- BUSERELIN
- Suprecur
- Suprefact
- Receptal
- Conceptal
- Estomal
- Buserelin monoacetate
- Suprafact
- Supremon
- Profact
- BuserelinAcetate
- Suprefact Depot
- Profact Depot
- Buserelin (Acetate)
- 68630-75-1
- Suprefact Flakon
- Buserelin CRS
- BSRL Acetate
- Acetate, Buserelin
- Suprecur (TN)
- HOE 766MP
- RefChem:54578
- BUSERELINE ACETATE
- HOE-766
- 13U86G7YSP
- Buserelin acetate [USAN:JAN]
- HOE 766 MP
- UNII-13U86G7YSP
- AC1L18OK
- HOE 766
- Hoe-766 MP
- NSC-725176
- SCHEMBL167553
- DTXSID30218712
- Buserelin acetate (JAN/USAN)
- HOE766
- orb1296665
- SCHEMBL1649201
- BUSERELIN ACETATE [JAN]
- BUSERELIN ACETATE [USAN]
- CHEMBL2106198
- SCHEMBL29394496
- CHEBI:31324
- C60H86N16O13.C2H4O2
- DTXCID80141203
- BUSERELIN ACETATE [MART.]
- MFCD01716229
- PYMDEDHDQYLBRT-DRIHCAFSSA-N
- BUSERELIN MONOACETATE [MI]
- GLXC-06434
- BUSERELIN ACETATE [WHO-DD]
- CID50224
- 8069AH
- C62H90N16O15
- CB-605
- HY-13581A
- NSC725176
- Buserelin for peak identification CRS
- AKOS032960353
- AKOS040763961
- AT41853
- BAT-015401
- CS-5962
- FP19363
- NSC 725176
- DA-51475
- LS-88235
- TS-10343
- 2216S
- NS00036669
- (Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH
- Buserelin Acetate (57982-77-1 free base)
- C13301
- D01831
- C60-H86-N16-O13.C2-H4-O2
- D-Ser (Bu(t))(6) Pro(9) NEt LHRH Acetate
- (Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH Acetate
- 57982-77-1
- Q27888490
- Buserelin Working Standard (Secondary Reference Standard)
- 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate (salt)
- H-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt.CH3CO2H
- pGlu-His-Trp-Ser-Tyr-D-Ser(t-Bu)-Leu-Arg-Pro-NHEt acetate sal t
- pGlu-His-Trp-Ser-Tyr-D-Ser(t-Bu)-Leu-Arg-Pro-NHEt acetate salt
- 6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor Monoacetate
- acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
- Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt)
- (2S)-1-[(2S)-2-[(2S)-2-[(2R)-3-(TERT-BUTOXY)-2-[(2S)-2-[(2S)-3-HYDROXY-2-[(2S)-2-[(2S)-3-(1H-IMIDAZOL-4-YL)-2-{[(2S)-5-OXOPYRROLIDIN-2-YL]FORMAMIDO}PROPANAMIDO]-3-(1H-INDOL-3-YL)PROPANAMIDO]PROPANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]PROPANAMIDO]-4-METHYLPENTANAMIDO]-5-CARBAMIMIDAMIDOPENTANOYL]-N-ETHYLPYRROLIDINE-2-CARBOXAMIDE; ACETIC ACID
- (S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-15-(tert-butoxymethyl)-21-(3-((diaminomethylene)amino)propyl)-12-(4-hydroxybenzyl)-9-(hydroxy
- (S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-15-(tert-butoxymethyl)-21-(3-((diaminomethylene)amino)propyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-
- 1-9-Luteinizing hormone-releasing factor (pig) 6-[O-(1 1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-monoacetate (salt)
- 1-9-Luteinizing hormone-releasing factor (swine) 6-[O-(1 1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-monoacetate (salt) (9CI)
- 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, acetate (1:1)
- 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt)
- 1-9-Luteinizing hormone-releasing factor (swine),1- dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt)
- 18-isobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-ethylpyrrolidine-2-carboxamide acetate
- 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-Luteinizing hormone-releasing factor (swine) acetate (1:1); 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt) (9CI); Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt); 1-9-Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-, monoacetate (salt); Buserelin acetate; Conceptal; Estomal; Gonaxal; Sprecur MP; Suprafact; Suprecur; Supremon
- Acetic acid--5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-N~5~-(diaminomethylidene)-L-ornithyl-N-ethyl-L-prolinamide (1/1)
- acetic acid; (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
- acetic acid;(2S)-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1R)-1-(tert-butoxymethyl)-2-[[(1S)-1-[[(1S)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl]-4-guanidino-butyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-1-[(4-hydroxyphenyl)methyl]-2-oxo-ethyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]-5-oxo-pyrrolidine-2-carboxamide
- Luteinizing hormone-releasing factor (pig) 6-[O-(1 1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-monoacetate (salt)
- methyl)-18-isobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-ethylpyrrolidine-2-carboxamide acetate